Reduced right/left ventricular blood pool T2-ratio predicts congestive heart failure after STEMI - Summary - MDSpire

Reduced right/left ventricular blood pool T2-ratio predicts congestive heart failure after STEMI

  • By

  • Felix Troger

  • Mathias Pamminger

  • Christina Tiller

  • Magdalena Holzknecht

  • Ivan Lechner

  • Alex Kaser

  • Philip Lungenschmid

  • Ramona Popa

  • Fritz Oberhollenzer

  • Martin Reindl

  • Bernhard Metzler

  • Sebastian J. Reinstadler

  • Agnes Mayr

  • February 17, 2026

  • 0 min

Share

Objective:

To measure the RV/LV T2-ratio in first-time STEMI patients and assess its association with major adverse cardiac events (MACE), particularly congestive heart failure (CHF), highlighting the significance of MACE in this context.

Key Findings:
  • Low RV/LV T2-ratios were associated with increased risk of CHF and MACE in STEMI patients, with specific statistical data to support these findings.
Interpretation:

The RV/LV T2-ratio could be a valuable imaging biomarker for predicting CHF in patients post-STEMI, potentially guiding clinical management and improving patient outcomes.

Limitations:
  • The study's findings are based on a single cohort and may not be generalizable to all STEMI patients; potential biases in the study design should also be acknowledged.
Conclusion:

The RV/LV T2-ratio is a promising predictor of CHF following STEMI, warranting further investigation in clinical settings to validate these findings.

Original Source(s)

Reduced right/left ventricular blood pool T2-ratio predicts congestive heart failure after STEMI

  • by Felix Troger, Mathias Pamminger, Christina Tiller, Magdalena Holzknecht, Ivan Lechner, Alex Kaser, Philip Lungenschmid, Ramona Popa, Fritz Oberhollenzer, Martin Reindl, Bernhard Metzler, Sebastian J. Reinstadler, Agnes Mayr

  • February 17, 2026

Related Content

Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.